Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.39 |
| ▸ | PRKCG | P05129 | 1/20 | 0.39 |
| ▸ | PRKCB | P05771 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | PRKCH | P24723 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.39 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.38 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.38 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.38 |
| ▸ | LPAR5 | Q9H1C0 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27629301 | 1.00 | DNM1 (0.48) | DNM1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL3502859 | 1.00 | DNM1 (0.48) | DNM1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL15160848 | 0.98 | DNM1 (0.45) | DNM1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL441733 | 0.90 | — | — | |
| SCHEMBL873400 | 0.87 | DNM1 (0.54) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL16841236 | 0.87 | DNM1 (0.54) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL25509452 | 0.87 | DNM1 (0.54) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL6686359 | 0.87 | DNM1 (0.54) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL683435 | 0.87 | HTT (0.50) | DNM1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL28557811 | 0.85 | DNM1 (0.50) | DNM1THRBTSHRLPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080071084-A1 | Using an alcohol in presence of copper catalyst and ligand | ARCHIMICA GMBH (DE) | 2008-03-20 | — | — | US | claimed |
| EP-1873136-A1 | Method for manufacturing alkyl and aryl ethers | Archimica GmbH (DE) | 2008-01-02 | — | — | EP | claimed |
| US-20170305848-A1 | SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170305848-A1 | SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-10-26 | — | — | US | disclosed |
| CN-102532162-B | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMA CO LTD | 2015-05-27 | — | — | CN | disclosed |
| CN-101255170-A | 2,3-dihydroimidazo[2,1-b]oxazole compound | OTSUKA PHARMA CO LTD (JP) | 2008-09-03 | — | — | CN | disclosed |
| CN-101172981-A | 2,3-dihydroimidazo[2,1-b]oxazole compound | OTSUKA PHARMA CO LTD (JP) | 2008-05-07 | — | — | CN | disclosed |
| US-20080071084-A1 | Using an alcohol in presence of copper catalyst and ligand | ARCHIMICA GMBH (DE) | 2008-03-20 | — | — | US | disclosed |
| CN-100366624-C | 2, 3-dihydro-6-nitroimidazo [2,1-b ] * azole compounds | OTSUKA PHARMA CO LTD (JP) | 2008-02-06 | — | — | CN | disclosed |
| EP-1873136-A1 | Method for manufacturing alkyl and aryl ethers | Archimica GmbH (DE) | 2008-01-02 | — | — | EP | disclosed |
| CN-1705670-A | 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds | OTSUKA PHARMA CO LTD (JP) | 2005-12-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305848-A1 | SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION | ARSA, SPIN1, ASIC1 | DNM1 1984/4885PRKD3 1173/4885PRKCG 2983/4885 |
| US-20080071084-A1 | Using an alcohol in presence of copper catalyst and ligand | NR1H3, NR1H2, ADH1A | DNM1 2704/4885PRKD3 4623/4885PRKCG 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.